The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

COVID-19 Solutions at Cornell University

Latest Innovations Immediately Available

The following are select COVID-19 related technologies ready for commercialization

 

 

Diagnostics


Point-of-Care-Testing for COVID-19
 
Ultra-rapid (<5 minutes), highly-sensitive, and highly-specific detection of COVID-19 (TET-VirusDX), that is both cost-effective and easy to use. Read more

 

 

Therapeutics


Tunable, Anti-inflammatory Immune Responsive Biomaterials for COVID-19 Treatment
 
A platform of anti-inflammatory polymeric biomaterials that provides tunable immune responses via the modulation of macrophage metabolism. Read more

 

 

Personal Protective Equipment (PPE)


Drinking Mask with Protection against Respiratory Illnesses
 
Protective mask (N-95, surgical, cloth, etc.) combined with an HME filter for safe drinking with others when social distancing is not possible. Read more

 

More Cornell COVID-19 Technologies

 

Connect With a Member of the Licensing and Business Development Team

 

 

Connecting and Collaborating with Cornell

Didn’t find the technology you’re looking for? Cornell University’s faculty, researchers, and entrepreneurs are accelerating and developing viable solutions to challenges created by the COVID-19 pandemic.

 

On our Ithaca and Cornell Tech campuses, CTL’s Innovation Partnerships and Business Development teams actively track innovations and exciting research across the entire enterprise.

 

Connect with a member of the Cornell team to learn more about our latest faculty research and collaboration opportunities.

 
 

Cornell Pledges to Licensing Frameworks for Rapid Utilization of COVID-19 Technologies

 

Cornell has joined with other leading research institutions in committing to making promising technologies available and has pledged to special licensing frameworks to help foster a rapid response to COVID-19 including the COVID-19 Technology Access Framework and AUTM’s COVID-19 Licensing Guidelines. Read more

 

 

Cornell Programs to Promote Commercialization and Partnership